Drug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications

Giulia Rivasi(Azienda Ospedaliero-Universitaria Careggi), Martina Rafanelli(Azienda Ospedaliero-Universitaria Careggi), Enrico Mossello(Azienda Ospedaliero-Universitaria Careggi), Michele Brignole(IRCCS Istituto Auxologico Italiano), Andrea Ungar(Azienda Ospedaliero-Universitaria Careggi)
Drugs & Aging
September 7, 2020
Cited by 153Open Access
Full Text

Abstract

Orthostatic hypotension (OH) is an abnormal blood pressure response to standing, which is associated with an increased risk of adverse outcomes such as syncope, falls, cognitive impairment, and mortality. Medical therapy is one the most common causes of OH, since numerous cardiovascular and psychoactive medications may interfere with the blood pressure response to standing, leading to drug-related OH. Additionally, hypotensive medications frequently overlap with other OH risk factors (e.g., advanced age, neurogenic autonomic dysfunction, and comorbidities), thus increasing the risk of symptoms and complications. Consequently, a medication review is recommended as a first-line approach in the diagnostic and therapeutic work-up of OH, with a view to minimizing the risk of drug-related orthostatic blood pressure impairment. If symptoms persist after the review of hypotensive medications, despite adherence to non-pharmacological interventions, specific drug treatment for OH can be considered. In this narrative review we present an overview of drugs acting on the cardiovascular and central nervous system that may potentially impair the orthostatic blood pressure response and we provide practical suggestions that may be helpful to guide medical therapy optimization in patients with OH. In addition, we summarize the available strategies for drug treatment of OH in patients with persistent symptoms despite non-pharmacological interventions.


Related Papers

No related papers found

Powered by citation graph analysis